Doody RS - Search Results

1

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators. Feldman HH, et al. Among authors: doody rs. Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3. Neurology. 2010. PMID: 20200346 Clinical Trial.

2

Progressive nonfluent aphasia with dementia: a case report.

Feher EP, Doody RS, Whitehead J, Pirozzolo FJ. Feher EP, et al. Among authors: doody rs. J Geriatr Psychiatry Neurol. 1991 Oct-Dec;4(4):236-40. doi: 10.1177/089198879100400411. J Geriatr Psychiatry Neurol. 1991. PMID: 1789913

3

The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.

Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A. Clark CM, et al. Neurology. 1997 Jul;49(1):70-5. doi: 10.1212/wnl.49.1.70. Neurology. 1997. PMID: 9222172

4

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. Rogers SL, et al. Among authors: doody rs. Neurology. 1998 Jan;50(1):136-45. doi: 10.1212/wnl.50.1.136. Neurology. 1998. PMID: 9443470 Clinical Trial.

5

The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease.

Doody RS, Vacca JL, Massman PJ, Liao TY. Doody RS, et al. Arch Neurol. 1999 Sep;56(9):1133-7. doi: 10.1001/archneur.56.9.1133. Arch Neurol. 1999. PMID: 10488815

6

Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?

Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Doody RS, et al. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):668-71. doi: 10.1136/jnnp.69.5.668. J Neurol Neurosurg Psychiatry. 2000. PMID: 11032626 Free PMC article.

7

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.

Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD; Donepezil Study Group. Doody RS, et al. Arch Neurol. 2001 Mar;58(3):427-33. doi: 10.1001/archneur.58.3.427. Arch Neurol. 2001. PMID: 11255446 Clinical Trial.

8

A method for estimating progression rates in Alzheimer disease.

Doody RS, Massman P, Dunn JK. Doody RS, et al. Arch Neurol. 2001 Mar;58(3):449-54. doi: 10.1001/archneur.58.3.449. Arch Neurol. 2001. PMID: 11255449 Clinical Trial.

9

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.

Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; "312" Study Group. Mohs RC, et al. Among authors: doody rs. Neurology. 2001 Aug 14;57(3):481-8. doi: 10.1212/wnl.57.3.481. Neurology. 2001. PMID: 11502917 Clinical Trial.

10

Current concepts in mild cognitive impairment.

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Petersen RC, et al. Arch Neurol. 2001 Dec;58(12):1985-92. doi: 10.1001/archneur.58.12.1985. Arch Neurol. 2001. PMID: 11735772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters